Welcome to our investor pages
Medical technology company Optomed is leading producer of handheld fundus cameras globally.
- Net sales 14,7 EUR, million
- Gross margin 68.7 %
- EBITDA -2,0 EUR, million
- Equity ratio 65.0%
Share Price
Nasdaq Helsinki Stock Exchange
Latest releases
Investor events
May 5
- May 5, 2023
Interim Report for 1 January – 31 March 2023
Aug 4
- Aug 4, 2023
Half-Year Financial Report for 1 January – 30 June 2023
Nov 3
- Nov 3, 2023
Interim Report for 1 January – 30 September 2023
Mar 14
- Mar 16, 2023
Carnegie Nordic Healthcare seminar in Stockholm
Mar 3
- Mar 3, 2023
SEB Finnish Small cap seminar
Feb 17
- Feb 17, 2023
Financial Statement Bulletin for 1 January – 31 December 2022
Optomed as an investment
Optomed is a research and development as well as sales driven medical technology company in expansion phase.
Optomed is one of the leading players in the growing and transforming handheld fundus camera market.
Read more
